Showing 1 - 15 results of 15 for search 'Xianling Liu', query time: 0.03s
Refine Results
-
1
Salvage radiotherapy strategy and its prognostic significance for patients with locoregional recurrent cervical cancer after radical hysterectomy: a multicenter retrospective 10-ye... by Minjie Shan, Yuping Deng, Wen Zou, Shasha Fan, Yanlong Li, Xianling Liu, Jingjing Wang
Published 2023-09-01
Article -
2
Gender differences in brain response to infant emotional faces by Kaihua Zhang, Xiaoyu Du, Xianling Liu, Wei Su, Zhenhua Sun, Mengxing Wang, Xiaoxia Du
Published 2022-12-01
Article -
3
Hypofractionated radiotherapy with immunochemotherapy for extensive-stage small-cell lung cancer by Chaoyuan Liu, Liang Zeng, Chao Deng, Wenjuan Jiang, Yapeng Wang, Yiguang Zhou, Li Liu, Sisi Wang, Chunhua Zhou, Zhenhua Qiu, Fanxu Zeng, Fang Wu, Jie Weng, Xianling Liu, Xianling Liu, Nong Yang, Fang Ma
Published 2023-06-01
Article -
4
Nomograms based on the lymphocyte–albumin–neutrophil ratio (LANR) for predicting the prognosis of nasopharyngeal carcinoma patients after definitive radiotherapy by Sujuan Zhang, Zui Chen, Jie Ling, Yuhua Feng, Yangchun Xie, Xianling Liu, Chunhong Hu, Tao Hou
Published 2024-03-01
Article -
5
Propensity score matching analysis to comparing cisplatin versus nedaplatin based doublet agent concurrent chemoradiotherapy for locally advanced cervical cancer by Yue Zhang, Shasha Fan, Minjie Shan, Wen Zou, Yeqian Feng, Tao Hou, Xianling Liu, Jingjing Wang
Published 2023-06-01
Article -
6
-
7
-
8
-
9
Case Report: ICIs-induced Guillain–Barré syndrome recovered from mycophenolate mofetil by Mengge Ding, Chao Deng, Xianling Liu, Shun Jiang, Yuan Gao, Dan Fan, Yiguang Zhou, Jiangbo He, Chaoyuan Liu
Published 2023-05-01
Article -
10
Real-world retrospective study of immune checkpoint inhibitors in combination with radiotherapy or chemoradiotherapy as a bladder-sparing treatment strategy for muscle-invasive bla... by Chao Xu, Wen Zou, Lei Zhang, Ran Xu, Yuan Li, Yeqian Feng, Runtian Zhao, Yinhuai Wang, Xianling Liu, Jingjing Wang
Published 2023-05-01
Article -
11
-
12
Primary breast diffuse large B‐cell lymphoma in the rituximab era: A retrospective study of the Chinese Southwest Oncology Group by Huawei Weng, Prem Raj Shrestha, Huangming Hong, Zegeng Chen, Le Yu, Yuyi Yao, Zhihui Zhang, Liqun Zou, Bo Zhu, Hui Zhou, Xianling Liu, Yao Liu, Hongqiang Guo, He Huang, Tongyu Lin
Published 2023-12-01
Article -
13
Development and validation of a radiomics-based nomogram for predicting a major pathological response to neoadjuvant immunochemotherapy for patients with potentially resectable non... by Chaoyuan Liu, Wei Zhao, Wei Zhao, Junpeng Xie, Huashan Lin, Xingsheng Hu, Chang Li, Youlan Shang, Yapeng Wang, Yingjia Jiang, Mengge Ding, Muyun Peng, Tian Xu, Ao’ran Hu, Yuda Huang, Yuan Gao, Xianling Liu, Jun Liu, Jun Liu, Jun Liu, Fang Ma
Published 2023-02-01
Article -
14
Cell-free DNA methylation markers for differential diagnosis of hepatocellular carcinoma by Biyuan Luo, Fang Ma, Hao Liu, Jixiong Hu, Le Rao, Chun Liu, Yongfang Jiang, Shuyu Kuangzeng, Xuan Lin, Chenyang Wang, Yiyu Lei, Zhongzhou Si, Guangshun Chen, Ning Zhou, Chengbai Liang, Fangqing Jiang, Fenge Liu, Weidong Dai, Wei Liu, Yawen Gao, Zhihong Li, Xi Li, Guangyu Zhou, Bingsi Li, Zhihong Zhang, Weiqi Nian, Lihua Luo, Xianling Liu
Published 2022-01-01
Article -
15
First-in-human phase I/Ib study of QL1706 (PSB205), a bifunctional PD1/CTLA4 dual blocker, in patients with advanced solid tumors by Yuanyuan Zhao, Yuxiang Ma, Aimin Zang, Ying Cheng, Yiping Zhang, Xiangcai Wang, Zhendong Chen, Song Qu, Jianbo He, Chuanben Chen, Chuan Jin, Dongyuan Zhu, Qingshan Li, Xianling Liu, Wuyun Su, Yi Ba, Yanrong Hao, Junmin Chen, Guoping Zhang, Shenhong Qu, Yong Li, Weineng Feng, Mengxiang Yang, Baorui Liu, Weiwei Ouyang, Jin Liang, Zhuang Yu, Xiaoyan Kang, Shilin Xue, Guihong Yang, Wei Yan, Yingying Yang, Zhi Liu, Yufeng Peng, Bill Fanslow, Xian Huang, Li Zhang, Hongyun Zhao
Published 2023-05-01
Article